◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Telo Genomics Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Jun 30, 2025 FY 2024Jun 30, 2024 FY 2023Jun 30, 2023 FY 2022Jun 30, 2022 FY 2021Jun 30, 2021
Total Revenue 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 --
Selling General And Administration 1.3M 1.4M 1.5M 986,628 --
General And Administrative Expense 1.3M 1.4M 1.5M 986,628 --
Research And Development 1.4M 1.4M 1.4M 1.1M --
Depreciation And Amortization In Income Statement -- -- -- 0.00 0.00
Operating Expense 2.7M 2.7M 2.8M 2.1M --
Operating Income -2.7M -2.7M -2.8M -2.1M --
EBIT -2.7M -2.7M -2.8M -2.1M --
Interest Expense -- -- -- -- 0.00
Interest Expense Non Operating -- -- -- -- 0.00
Net Interest Income -- -- -- -- 0.00
Other Income Expense -16,371 10,000 -- -- 187,234
Other Non Operating Income Expenses -- -- -- -- 183,484
Special Income Charges -16,371 10,000 0.00 0.00 --
Pretax Income -2.7M -2.7M -2.8M -2.1M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -2.7M -2.7M -2.8M -2.1M --
Net Income From Continuing Operation Net Minority Interest -2.7M -2.7M -2.8M -2.1M --
Net Income Including Noncontrolling Interests -2.7M -2.7M -2.8M -2.1M --
Net Income Common Stockholders -2.7M -2.7M -2.8M -2.1M --
Net Income -2.7M -2.7M -2.8M -2.1M --
EBITDA -2.7M -2.7M -2.8M -2.1M --
Normalized EBITDA -2.7M -2.7M -2.8M -2.1M --
Reconciled Depreciation 14,452 39,536 33,114 56,956 --
Basic EPS -0.03 -0.04 -0.05 -0.04 --
Diluted EPS -0.03 -0.04 -0.05 -0.04 --
Basic Average Shares 87.7M 71.4M 60.2M 58.7M --
Diluted Average Shares 87.7M 71.4M 60.2M 58.7M --
Total Unusual Items -16,371 10,000 0.00 0.00 --
Total Unusual Items Excluding Goodwill -16,371 10,000 0.00 0.00 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 --
Normalized Income -2.7M -2.7M -2.8M -2.1M --
Depreciation Amortization Depletion Income Statement -- -- -- 0.00 0.00
Depreciation Income Statement -- -- -- 0.00 0.00
Diluted NI Availto Com Stockholders -2.7M -2.7M -2.8M -2.1M --
Impairment Of Capital Assets 16,371 0.00 -- -- --
Net Income Continuous Operations -2.7M -2.7M -2.8M -2.1M --
Net Non Operating Interest Income Expense -- -- -- -- 0.00
Other Gand A 1.3M 1.4M 1.5M 986,628 --
Other Special Charges -- -10,000 -- -- -187,234
Salaries And Wages -- -- -- 180,497 141,551
Total Expenses 2.7M 2.7M 2.8M 2.1M --
Line Item FY 2025Jun 30, 2025 FY 2024Jun 30, 2024 FY 2023Jun 30, 2023 FY 2022Jun 30, 2022 FY 2021Jun 30, 2021
Cash And Cash Equivalents 789,293 796,020 2.7M 2.7M --
Cash Cash Equivalents And Short Term Investments 789,293 796,020 2.7M 2.7M --
Cash Financial 789,293 796,020 2.7M -- 3.6M
Accounts Receivable 26,539 31,249 63,763 37,977 --
Receivables 26,539 31,249 63,763 37,977 --
Prepaid Assets 76,430 91,764 105,934 55,606 --
Current Assets 892,262 919,033 2.8M 2.8M --
Gross PPE 950,072 946,822 944,906 875,844 --
Accumulated Depreciation -931,034 -916,582 -878,646 -845,532 --
Net PPE 19,038 30,240 66,260 30,312 --
Goodwill And Other Intangible Assets 0.00 16,371 16,371 16,371 --
Total Non Current Assets 19,038 46,611 82,631 46,683 --
Total Assets 911,300 965,644 2.9M 2.8M --
Payables And Accrued Expenses 396,319 375,587 280,369 190,072 --
Current Liabilities 396,319 375,587 280,369 190,072 --
Long Term Debt -- -- 32,500 40,000 40,000
Long Term Debt And Capital Lease Obligation -- -- 32,500 40,000 40,000
Total Non Current Liabilities Net Minority Interest 0.00 0.00 32,500 40,000 --
Total Liabilities Net Minority Interest 396,319 375,587 312,869 230,072 --
Common Stock 24.6M 22.3M 21.7M 19.1M --
Capital Stock 24.6M 22.3M 21.7M 19.1M --
Additional Paid In Capital 6.4M 6.1M 6.0M 5.8M --
Retained Earnings -30.5M -27.8M -25.1M -22.3M --
Common Stock Equity 514,981 590,057 2.6M 2.6M --
Stockholders Equity 514,981 590,057 2.6M 2.6M --
Total Equity Gross Minority Interest 514,981 590,057 2.6M 2.6M --
Total Capitalization 514,981 590,057 2.6M 2.6M --
Net Tangible Assets 514,981 573,686 2.6M 2.6M --
Tangible Book Value 514,981 573,686 2.6M 2.6M --
Working Capital 495,943 543,446 2.6M 2.6M --
Invested Capital 514,981 590,057 2.6M 2.6M --
Total Debt -- -- 32,500 40,000 40,000
Share Issued 100.0M 74.6M 71.2M 59.4M --
Ordinary Shares Number 100.0M 74.6M 71.2M 59.4M --
Machinery Furniture Equipment 950,072 946,822 944,906 875,844 --
Other Equity Interest 50,369 -- 42,000 -- --
Restricted Cash -- -- 0.00 2,000 --
Line Item FY 2025Jun 30, 2025 FY 2024Jun 30, 2024 FY 2023Jun 30, 2023 FY 2022Jun 30, 2022 FY 2021Jun 30, 2021
Operating Cash Flow -2.3M -2.5M -2.6M -1.8M --
Cash Flow From Continuing Operating Activities -2.3M -2.5M -2.6M -1.8M --
Depreciation And Amortization 14,452 39,536 33,114 56,956 --
Depreciation Amortization Depletion 14,452 39,536 33,114 56,956 --
Stock Based Compensation 268,051 64,557 160,168 151,408 --
Change In Working Capital 40,776 158,154 -2,069 107,099 --
Change In Receivables 4,710 32,514 -25,786 58,753 --
Change In Payables And Accrued Expense 20,732 111,470 74,045 76,416 --
Other Non Cash Items 50,369 -- -- -- -183,484
Capital Expenditure -3,250 -5,115 -69,062 -25,193 --
Purchase Of PPE -3,250 -5,115 -69,062 -- -9,310
Net PPE Purchase And Sale -3,250 -5,115 -69,062 -25,193 --
Investing Cash Flow -3,250 -5,115 -69,062 -25,193 --
Cash Flow From Continuing Investing Activities -3,250 -5,115 -69,062 -25,193 --
Repayment Of Debt 0.00 -22,500 -7,500 0.00 --
Net Issuance Payments Of Debt 0.00 -22,500 -7,500 0.00 --
Issuance Of Capital Stock 2.5M 650,000 2.8M 195,000 --
Net Common Stock Issuance 2.5M 650,000 2.8M 195,000 --
Financing Cash Flow 2.3M 587,052 2.7M 876,647 --
Cash Flow From Continuing Financing Activities 2.3M 587,052 2.7M 876,647 --
Changes In Cash -6,727 -1.9M -19,718 -943,537 --
Beginning Cash Position 796,020 2.7M 2.7M 3.6M --
End Cash Position 789,293 796,020 2.7M 2.7M --
Free Cash Flow -2.3M -2.5M -2.7M -1.8M --
Income Tax Paid Supplemental Data -- -- -- 0.00 0.00
Interest Paid Supplemental Data -- -- -- 0.00 0.00
Asset Impairment Charge 16,371 0.00 -- -- --
Change In Prepaid Assets 15,334 14,170 -50,328 -28,070 --
Common Stock Issuance 2.5M 650,000 2.8M 195,000 --
Depreciation 14,452 39,536 33,114 56,956 --
Gain Loss On Sale Of PPE 0.00 1,599 0.00 -- --
Long Term Debt Payments 0.00 -22,500 -7,500 0.00 --
Net Income From Continuing Operations -2.7M -2.7M -2.8M -2.1M --
Net Long Term Debt Issuance 0.00 -22,500 -7,500 0.00 --
Net Other Financing Charges -220,643 -40,448 -207,472 -16,661 --
Operating Gains Losses -- -8,401 -- -- -3,750
Proceeds From Stock Option Exercised -- 0.00 60,000 698,308 1.9M
NEWS
Loading news...
TRENDING
Loading...